Infectious Disease Diagnostics Market to Hit $37.94 Billion, Globally, by 2028 – Exclusive Report by The Insight Partners
September 20, 2023 10:22 ET
|
The Insight Partners
Pune, India., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Tuberculosis (TB) is the 13th most significant cause of mortality globally and the second leading infectious disease after COVID-19, according to the...
CytoSorbents And Humedics Announce Theranostic Collaboration in the Field of Liver Disease
July 11, 2023 07:00 ET
|
CytoSorbents
PRINCETON, N.J., July 11, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
Hepatitis C Market to grow at a CAGR of 13.60 percent reaching USD 103.2 Bn by 2029
May 26, 2023 07:54 ET
|
MAXIMIZE MARKET RESEARCH PRIVATE LIMITED
Pune, May 26, 2023 (GLOBE NEWSWIRE) -- Maximize Market Research, a global Healthcare market research firm has published a competitive intelligence market research report on the “Hepatitis C Market“....
Anti-Viral Therapies Market Growth ($82.92 Billion by 2028) Driven by Branded Drugs Segment during (2022-2028) – Global Report by The Insight Partners
March 09, 2023 08:46 ET
|
The Insight Partners
New York, March 09, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Anti-Viral Therapies Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global...
Global Liver Disease Treatment Market Anticipated to Garner $32,028.5 Million, Growing with 11.7% CAGR in the 2021–2028 Timeframe [240-Pages] | Wrap up by Research Dive
October 12, 2022 08:59 ET
|
Research Dive
New York, USA, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Research Dive has published a new report on the global liver disease treatment market. According to the report, the global market is projected to...
Vir Biotechnology Announces First Patient Dosed in the Phase 2 SOLSTICE Trial Evaluating VIR-2218 and VIR-3434 for the Treatment of Chronic Hepatitis D Virus Infection
September 22, 2022 08:00 ET
|
Vir Biotechnology, Inc.
– Impacting more than 12 million people globally, HDV is the most aggressive form of viral hepatitis – – Novel combination strategy designed toreduce HDV viremia and block viral entry – SAN...
Interferons Market Projected to Exhibit at a Steady CAGR of 3.9% by 2032 – Future Market Insights, Inc.
July 28, 2022 06:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, July 28, 2022 (GLOBE NEWSWIRE) -- As per a latest industry analysis by Future Market Insights, the global interferons market was valued at around US$ 9.1 Bn in 2021 and is anticipated...
'I Can't Wait' is the Campaign Theme for World Hepatitis Day 2022
July 28, 2022 00:15 ET
|
World Hepatitis Alliance
LONDON, England, July 28, 2022 (GLOBE NEWSWIRE) -- Today, World Hepatitis Day (WHD) launches with the campaign theme 'I Can't Wait'. On WHD, the World Hepatitis Alliance (WHA) joins together with...
Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™
June 25, 2022 04:00 ET
|
Immunocore Holdings Limited
PRESS RELEASE Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™ IMC-I109V, T cell receptor...
Vaccines Market revenue worth USD 96.1 billion by 2028, Says Global Market Insights Inc.
May 09, 2022 06:15 ET
|
Global Market Insights Inc.
Selbyville, Delaware, May 09, 2022 (GLOBE NEWSWIRE) -- The vaccines market value is expected to reach USD 96.1 billion by 2028 , according to a new research report by Global Market Insights Inc....